Core Viewpoint - In 2024, Novogene achieved a revenue of 1.378 billion RMB, marking a year-on-year growth of 7.15%, while the net profit attributable to the parent company was a loss of 18.09 million RMB, which represents a reduction in losses by 52.86 million RMB compared to the previous year [1][2]. Financial Performance - The total revenue for 2024 was 1,377,898,264.65 RMB, up 7.15% from 1,285,988,243.93 RMB in 2023 [2]. - The net profit attributable to the parent company was -18,093,809.99 RMB, an improvement from -70,956,239.35 RMB in 2023 [2]. - The net profit after deducting non-recurring gains and losses was -83,215,469.70 RMB, compared to -192,739,350.74 RMB in the previous year, indicating a reduction in losses by 110 million RMB [2]. Cash Flow and Assets - The net cash flow from operating activities was -9,681,648.68 RMB, a significant decline of 106.33% from 152,987,968.81 RMB in 2023 [2]. - Total assets decreased by 12.14% to 5,048,663,079.32 RMB from 5,746,172,538.46 RMB in 2023 [2]. Executive Compensation - The total compensation for current and former directors, supervisors, and core technical personnel in 2024 was 10.6682 million RMB, an increase of 20.66% from 8.8418 million RMB in 2023 [2]. - The chairman and general manager, Cao Lin, received a salary of 1.3982 million RMB, reflecting a year-on-year increase of 91.56% [3]. - Other executives also saw significant salary increases, with the vice president Zhang Lijun's salary rising by 97.4% to 1.3291 million RMB [3].
诺唯赞2024年营收增长、净利减亏,3名董监高涨薪超90%